T. Rowe Price Associates’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,450	Closed	-$101K	–	2592
2018 Q3	$101K	Buy	10,450 +185	+2%	+$1.79K	﹤0.01%	2520
2018 Q2	$105K	Buy	10,265 +53	+0.5%	+$542	﹤0.01%	2511
2018 Q1	$133K	Buy	+10,212	New	+$133K	﹤0.01%	2456